Sabal Trust CO Has $53.62 Million Position in JPMorgan Chase & Co. (NYSE:JPM)

Sabal Trust CO lowered its stake in JPMorgan Chase & Co. (NYSE:JPM) by 6.1% in the 4th quarter, HoldingsChannel.com reports. The firm owned 223,676 shares of the financial services provider’s stock after selling 14,637 shares during the period. JPMorgan Chase & Co. comprises 3.1% of Sabal Trust CO’s holdings, making the stock its 2nd largest position. Sabal Trust CO’s holdings in JPMorgan Chase & Co. were worth $53,617,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. JPMorgan Chase & Co. lifted its position in JPMorgan Chase & Co. by 7.7% in the third quarter. JPMorgan Chase & Co. now owns 4,450,775 shares of the financial services provider’s stock valued at $938,491,000 after purchasing an additional 319,730 shares during the last quarter. Kingsview Wealth Management LLC lifted its position in JPMorgan Chase & Co. by 2.5% in the third quarter. Kingsview Wealth Management LLC now owns 118,095 shares of the financial services provider’s stock valued at $24,902,000 after purchasing an additional 2,839 shares during the last quarter. Brighton Jones LLC lifted its position in JPMorgan Chase & Co. by 11.0% in the fourth quarter. Brighton Jones LLC now owns 48,732 shares of the financial services provider’s stock valued at $11,682,000 after purchasing an additional 4,841 shares during the last quarter. Zions Bancorporation N.A. lifted its position in JPMorgan Chase & Co. by 2.5% in the third quarter. Zions Bancorporation N.A. now owns 11,157 shares of the financial services provider’s stock valued at $2,353,000 after purchasing an additional 267 shares during the last quarter. Finally, Algert Global LLC bought a new stake in JPMorgan Chase & Co. in the third quarter valued at approximately $3,017,000. Institutional investors own 71.55% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. Robert W. Baird upgraded JPMorgan Chase & Co. from an “underperform” rating to a “neutral” rating and upped their target price for the company from $215.00 to $220.00 in a report on Friday. Citigroup increased their target price on JPMorgan Chase & Co. from $215.00 to $250.00 and gave the stock a “neutral” rating in a research note on Tuesday, November 19th. Oppenheimer cut JPMorgan Chase & Co. from an “outperform” rating to a “market perform” rating in a research note on Wednesday, November 20th. Keefe, Bruyette & Woods increased their target price on JPMorgan Chase & Co. from $257.00 to $264.00 and gave the stock a “market perform” rating in a research note on Thursday, January 16th. Finally, Bank of America upped their price target on JPMorgan Chase & Co. from $260.00 to $280.00 and gave the company a “buy” rating in a report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and ten have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $252.89.

JPMorgan Chase & Co. Stock Down 1.7 %

NYSE JPM opened at $242.41 on Friday. The stock’s 50-day moving average price is $259.41 and its 200-day moving average price is $238.26. The company has a quick ratio of 0.89, a current ratio of 0.88 and a debt-to-equity ratio of 1.24. JPMorgan Chase & Co. has a 52 week low of $179.20 and a 52 week high of $280.25. The company has a market capitalization of $677.81 billion, a P/E ratio of 12.28, a price-to-earnings-growth ratio of 2.83 and a beta of 1.10.

JPMorgan Chase & Co. (NYSE:JPM) last posted its quarterly earnings data on Wednesday, January 15th. The financial services provider reported $4.81 EPS for the quarter, topping the consensus estimate of $4.03 by $0.78. JPMorgan Chase & Co. had a return on equity of 16.99% and a net margin of 20.96%. The firm had revenue of $42.77 billion for the quarter, compared to the consensus estimate of $41.90 billion. During the same quarter last year, the company earned $3.04 earnings per share. The business’s revenue for the quarter was up 10.9% compared to the same quarter last year. On average, equities research analysts predict that JPMorgan Chase & Co. will post 18.1 earnings per share for the current year.

JPMorgan Chase & Co. Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Monday, January 6th were given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 2.06%. The ex-dividend date was Monday, January 6th. JPMorgan Chase & Co.’s dividend payout ratio is currently 25.33%.

Insider Buying and Selling

In other JPMorgan Chase & Co. news, insider Robin Leopold sold 1,250 shares of the firm’s stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $270.09, for a total transaction of $337,612.50. Following the completion of the transaction, the insider now owns 50,377 shares in the company, valued at $13,606,323.93. This trade represents a 2.42 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, COO Jennifer Piepszak sold 4,273 shares of the firm’s stock in a transaction that occurred on Thursday, February 20th. The shares were sold at an average price of $269.85, for a total value of $1,153,069.05. Following the transaction, the chief operating officer now owns 54,469 shares of the company’s stock, valued at $14,698,459.65. This represents a 7.27 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 46,326 shares of company stock worth $12,448,445. 0.79% of the stock is owned by corporate insiders.

JPMorgan Chase & Co. Company Profile

JPMorgan Chase & Co is a financial holding company, which engages in the provision of financial and investment banking services. The firm offers a range of investment banking products and services in all capital markets, including advising on corporate strategy and structure, capital raising in equity and debt markets, risk management, market making in cash securities and derivative instruments, and brokerage and research.